Form 4: Viatris Inc. Executive Paul Campbell Reports Stock Transactions
SEC Form 4
Paul Campbell, Chief Accounting Officer and Corporate Controller of Viatris Inc., reports the vesting and disposal of restricted stock units (RSUs) and performance restricted stock units (PRSUs) to cover tax liabilities, as well as the acquisition of additional RSUs.
Summary
- On March 5, 2024, Paul Campbell, Chief Accounting Officer and Corporate Controller of Viatris Inc., filed a Form 4 detailing changes in beneficial ownership of Viatris stock.
- The reported transactions include the vesting of Performance Restricted Stock Units (PRSUs) and Restricted Stock Units (RSUs) granted on various dates (March 2, 2021, March 3, 2023, March 4, 2022 and March 4, 2024).
- Campbell also disposed of shares to cover tax liabilities associated with the vesting of these units.
- Additionally, Dividend Equivalent Units (DEUs) accrued with respect to the RSUs also vested.
- The transactions resulted in an adjusted direct ownership of 153,826 shares of Viatris common stock and indirect ownership of 318 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
Future vesting dates for RSUs are scheduled for March 3, 2025, March 3, 2026, March 4, 2025, March 4, 2026 and March 4, 2027.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the executive's stake in the company.
Comparison to Industry Standards
- Executive compensation practices, including the use of RSUs and PRSUs, are standard across the pharmaceutical industry.
- Companies like Teva Pharmaceutical Industries and Novartis also utilize similar equity-based compensation plans for their executives.
- The vesting schedules and performance metrics associated with these units are typically aligned with industry benchmarks and company-specific goals.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and alignment of interests.
- Employees holding similar stock-based compensation may be interested in the vesting schedules and tax implications.
- The transactions have a minimal direct impact on customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/02/2021 | Initial grant date of some Performance Restricted Stock Units (PRSUs) and Restricted Stock Units (RSUs). |
| 03/02/2022 | Vesting date of a portion of the RSUs granted on March 2, 2021. |
| 03/03/2023 | Initial grant date of some Restricted Stock Units (RSUs). |
| 03/02/2023 | Vesting date of a portion of the RSUs granted on March 2, 2021. |
| 03/04/2022 | Initial grant date of some Restricted Stock Units (RSUs). |
| 03/02/2024 | Vesting date of PRSUs granted on March 2, 2021 and a portion of RSUs granted on March 2, 2021. |
| 03/03/2024 | Vesting date of a portion of the RSUs granted on March 3, 2023. |
| 03/04/2024 | Vesting date of a portion of the RSUs granted on March 4, 2022. |
| 03/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.